del Pino / Pelaz

Research themes

Functional Nanoestructured Materials: Tools for Biomedical Applications

Main researcher(s)

Group members

Pérez Potti, André
Junior Scientist
Alameda Felgueiras, María Teresa

Postdoctoral Researcher

Ceballos Guzmán, Juan Manuel

Postdoctoral Researcher

Cruz Ortiz, Andrés Felipe

Postdoctoral Researcher

Da Silva Álvarez, Sabela

Postdoctoral Researcher

Fazal, Sajid

Postdoctoral Researcher

Padín González, Esperanza

Postdoctoral Researcher

Velasco Rodríguez, Brenda

Postdoctoral Researcher

Zampini, Giulia

Postdoctoral Researcher

Aguilera Llavero, María

PhD Candidate

Cabello Huerta, Mar

PhD Candidate

Durán Bravo, Álvaro

PhD Candidate

Fernández Iglesias, Antía

PhD Candidate

Fernández Vega, Javier

PhD Candidate

Funes Hernando, Samuel

PhD Candidate

Gkoutzamanis, Antonios

PhD Candidate

Liodakis, Nikolaos

PhD Candidate

Sánchez Martínez, Laura

PhD Candidate

Zerrouk, Fatima

PhD Candidate

Research

Welcome to the research site of the BioNanoTools laboratory at CIQUS.

Our research is focused on the development of multifunctional composite materials for applications in biology and medicine. We design, synthesize and customize nano- and micro-materials with applications in therapy, diagnostics and imaging.

We are working at the interface of materials science, biology and medicine with the goal of producing next generation "smart" materials, having enhanced multifunctional capabilities.

We are interested in exploring radically new solutions to scientific challenges in biology and medicine, as well as in basic research in materials with interesting new properties (e.g., nanoMOFs, nanoperovskites, etc.).

See more details in the description of our research lines.

 

COLLOIDAL NANOPARTICLES (NPs)

We develop, optimize and adapt bottom-up synthetic routes for the production of NPs made of different inorganic materials, such as QDs, plasmonic NPs (Au, Ag, Cu), and magnetic NPs (iron oxides, FePt, Mn/Co/Zn Fe-substituted ferrites). We can easily adjust the size, shape and coatings, which allow us to produce colloidally stable, robust NPs for a variety of bio-applications.

Currently, we also work on the production of nanocomposites based on inorganic NPs and MOF (metal-organic frameworks), as well as other exciting, new materials, such as NPs made of perovskite semiconductors.

Fig. 1: A) Aqueous stable luminescent perovskite-polymer composites; Appl. Mater. Today 2019, 15, 562-569. B) Core(NP)@shell(MOF) Au-nanostar@ZIF-8 nanocomposites; Angew. Chem. Int. Ed. 2019, 58, 7078-7082. ; Pd-Nanopartilces@ZIF-8, Cell Rep. Phys. Sci. 2020, 1(6), 100076. Different MOFs: ZIF-8, ZIF-90, UiO66, etc.

 

DNA-ORIGAMIS AS PRINTERS TO MODIFY THE SURFACE OF COLLOIDAL NANOMATERIALS 

DNA strands can be folded on-demand to produce 3D structures with almost atomic precision (DNA-origamis). Our goal is to adapt this technology to produce molecular nanoprinters capable to imprint 3D ligand patters on the surface of nanomaterials, aiming mimicking, for example, the protein patters that viruses express naturally in their capsids. The outcomes of this project will help us to understand how the number and the special disposition of the ligands determine not only how nanomaterials interact with cells but also their biological fate. All these will lead to the design of more efficient nanomedicines.

Fig. 2: “Nanoprinters” builds with DNA-origamis to funtionalize the surface of colloidal nanomaterials.
  

NANOHEATING & NANOREACTORS

Interaction of light or AMF with inorganic NPs is orders of magnitude stronger than with organic molecules, in particular due to their larger absorption cross-sections. Therefore inorganic NPs offer a convenient platform for remotely controlled heating via light or AMF.

We develop very efficient multifunctional nanoheaters based on plasmonic or magnetic NPs for a variety of bioapplications, such as photothermal therapy, magnetic hyperthermia, optoacoustic imaging and thermal biosensing.

 
 
Fig. 3: Triggered release: A thermoresponsive carrier comprising gold nanostars coated with ZIF‐8 stabilized with an amphiphilic polymer was developed for the light‐triggered release of encapsulated cargo inside cells. This nanocomposite, which is stable in aqueous solution (even when stored in cells), combines thermoplasmonic and high drug‐loading capabilities. Angew. Chem. Int. Ed. 2019, 58, 7078-7082.
  
 

STIMULI-RESPONSIVE DRUG CARRIERS

We develop multifunctional, composite carriers based on layer-by-layer polymer capsules and plasmonic/magnetic NPs, which upon interaction with external stimuli, such as light or alternating magnetic fields (AMF), release their content into the cytosol of cells.

We can encapsulate a variety of macromolecules of bio-medical relevance, including siRNA, miRNA, proteins, small hydrophobic drugs, etc.

  
Fig. 4: In vivo scheme to evaluate the ultrasound-triggered drug release. J. Control. Release 2019, 308, 162–171
 
 

SMART BIOMIMETIC NANOSYSTEMS

We seek for developing the next generation of “smart” biomimetic materials, mimicking natural cellular structures (such as cell membranes) with the goal of producing stimuli-responsive drug delivery nanoformulations. Translating cell membrane features and thus, being capable of implementing their surface properties on nanomedicines, offer exciting opportunities to fabricate next generation biomimetic nanoformulations with enhanced pharmacokinetic and tissue-specific targeting capabilities. Such biomimetic interfaces have emerged to overcome the main drawbacks inherent to synthetic nanomaterials. Cell membrane-derived nanostructures have proven to be the future of bioinspired synthetic nanocarriers for vaccines and drug-delivery systems.

We design novel biological nanostructures (biomimetic nanosystems), which combine cell membrane components and inorganic NPs to create functional nano bio-inorganic assemblies with physical (e.g., inorganic NPs) and biomimetic capabilities. We aim to develop a novel class of a versatile stimuli response drug delivery system for potential application in the treatment of diseases with specificity, by selecting the specific cargo and a biomimetic coating capable of achieving in vivo targeting and evading the host defense system.

Fig. 5: A) Production of biomimetic nanosystems (Cellsomes), which as cargo encapsulate drugs/biomolecules and NPs. The nanosystems mimics the cell membrane from which they were extracted. B) Schematic representation of cellsomes functionalized with GNRs and antibodies (Abs) as a cargo. In vitro NIR light triggered release of anti-tubulin Ab from GNRs functionalized cellsomes inside the cytosol of HeLa cells. The green colour indicates the fluorescence signal from the cellsomes and the red colour indicates the fluorescence signal from the Alexa-555 Ab encapsulated inside the cellsomes. After NIR laser illumination, the red fluorescence signal is observed in the cytosol of the cell. Adv. Biosys. 2020, 4(3),1900260.
 

NANOBIOINTERACTIONS

We are interested in characterizing the interaction of “our” materials with biologically relevant entities, such as proteins (protein corona), cells and animals.

Therefore, we use and develop methods (e.g., colloidal stability, nanotoxicology, internalization, etc.) to assess the impact of our materials in living entities, as well as to characterize what happens to “our materials” in biologically relevant environments (e.g., cell cultures, animals, etc.).

Fig. 6: Different scenarios and biological barriers in which NPs are present once they are injected in vivo. ACS Nano, 2017, 11 (3), pp 2397–2402.